These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
17. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation. Conti P; Ronconi G; Lauritano D; Mastrangelo F; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Carinci F; Gaudelli F; Annicchiarico C; D'Ovidio C Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542222 [TBL] [Abstract][Full Text] [Related]
18. Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers. Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa Al; Conti P J Biol Regul Homeost Agents; 2016; 30(4):945-950. PubMed ID: 28078840 [TBL] [Abstract][Full Text] [Related]
19. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells. Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074 [TBL] [Abstract][Full Text] [Related]
20. Induction of Microglial Activation by Mediators Released from Mast Cells. Zhang X; Wang Y; Dong H; Xu Y; Zhang S Cell Physiol Biochem; 2016; 38(4):1520-31. PubMed ID: 27050634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]